For: | Ma HN, Cao KS, Liu YM, Chen C, Zhang H, Tang FS. Tenofovir amibufenamide: A potential alternative for chronic hepatitis B treatment. World J Gastroenterol 2025; 31(10): 102580 [PMID: 40093664 DOI: 10.3748/wjg.v31.i10.102580] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v31/i10/102580.htm |
Number | Citing Articles |
1 |
Zhi-Hao Zeng, Jin-Qing Liu, Min Zhang, Cai-Liang Qiu, Zhen-Yu Xu. Tenofovir amibufenamide in chronic hepatitis B: Lipid changes and 144-week safety with tenofovir disoproxil fumarate-to-tenofovir amibufenamide switch. World Journal of Gastroenterology 2025; 31(26): 109285 doi: 10.3748/wjg.v31.i26.109285
Abstract(23) |
Core Tip(25) |
Full Article(HTML)(110)
|
Full Article with Cover (PDF)-2247K(4)
|
Audio-238K(1)
|
Peer-Review Report-331K(6)
|
Answering Reviewers-565K(5)
|
Supplementary Material-101K(6)
|
Full Article (PDF)-1884K(10)
|
Full Article (XML)-95K(5)
|
Times Cited (0)
|
Total Visits (318)
|
Open
|